| scholarly article | Q13442814 |
| P50 | author | Steven Z. Pavletic | Q20685099 |
| Jonathan S. Serody | Q38327188 | ||
| Ivan Maillard | Q57728609 | ||
| Stefanie Sarantopoulos | Q62050367 | ||
| Bruce R Blazar | Q62070764 | ||
| Corbin D. Jones | Q64871726 | ||
| Nelson J Chao | Q88101634 | ||
| Pei Fen Kuan | Q88250059 | ||
| Frances T Hakim | Q88466139 | ||
| Mitchell E Horwitz | Q88550273 | ||
| Kouros Owzar | Q91953147 | ||
| Jonathan C Poe | Q96203725 | ||
| Kouros Owzar | Q96203727 | ||
| P2093 | author name string | Christian W Siebel | |
| Wei Jia | |||
| Vincent T Ho | |||
| Jeremy J Rose | |||
| Hsuan Su | |||
| Benjamin G Vincent | |||
| Amy N Suthers | |||
| Prasanthi V Tata | |||
| Sarah Anand | |||
| P2860 | cites work | Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk | Q24303475 |
| Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation | Q24537575 | ||
| Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission | Q24539030 | ||
| B cells in chronic graft-versus-host disease | Q26861706 | ||
| Therapeutic antibody targeting of individual Notch receptors | Q27660544 | ||
| The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease | Q28076264 | ||
| IRTAs: a new family of immunoglobulinlike receptors differentially expressed in B cells | Q28212278 | ||
| Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program | Q28216493 | ||
| BAFF, APRIL and human B cell disorders | Q28258436 | ||
| Lunatic and manic fringe cooperatively enhance marginal zone B cell precursor competition for delta-like 1 in splenic endothelial niches | Q28508335 | ||
| Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing | Q33531727 | ||
| Identification of a human splenic marginal zone B cell precursor with NOTCH2-dependent differentiation properties | Q33569820 | ||
| Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans | Q33781179 | ||
| Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation. | Q33815631 | ||
| Toll-like receptor 9 signaling acts on multiple elements of the germinal center to enhance antibody responses | Q34025386 | ||
| Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development | Q34197865 | ||
| Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells | Q34282966 | ||
| Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors | Q34312702 | ||
| Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE). | Q34756619 | ||
| Ibrutinib treatment ameliorates murine chronic graft-versus-host disease | Q35140097 | ||
| Aberrant B-cell homeostasis in chronic GVHD | Q35171251 | ||
| Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease | Q35784522 | ||
| B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways | Q36250962 | ||
| A role for interferon regulatory factor 4 in receptor editing | Q36540253 | ||
| Vitamin A supplementation and retinoic acid treatment in the regulation of antibody responses in vivo | Q36763133 | ||
| Repertoire-based selection into the marginal zone compartment during B cell development | Q36853407 | ||
| Circulating T follicular helper cells with increased function during chronic graft-versus-host disease | Q36920466 | ||
| Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4 | Q36949425 | ||
| Retinoids accelerate B lineage lymphoid differentiation | Q37001761 | ||
| Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease | Q37162874 | ||
| A role for IRF8 in B cell anergy | Q37394553 | ||
| IRF4 controls the positioning of mature B cells in the lymphoid microenvironments by regulating NOTCH2 expression and activity. | Q37397830 | ||
| Increased BCR responsiveness in B cells from patients with chronic GVHD. | Q37670076 | ||
| Fibroblastic niches prime T cell alloimmunity through Delta-like Notch ligands | Q37730667 | ||
| Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. | Q37734578 | ||
| National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report | Q38405199 | ||
| ERK1/2 has an essential role in B cell receptor- and CD40-induced signaling in an in vitro model of germinal center B cell selection | Q38866165 | ||
| Chronic graft-versus-host disease: biological insights from preclinical and clinical studies | Q39002164 | ||
| Mechanistic approaches for the prevention and treatment of chronic GVHD. | Q39002166 | ||
| The MAPK/ERK and PI3K pathways additively coordinate the transcription of recombination-activating genes in B lineage cells | Q39667386 | ||
| Evidence of marginal-zone B cell-positive selection in spleen | Q40372076 | ||
| IRF4 Is a Critical Gene in Retinoic Acid-Mediated Plasma Cell Formation and Is Deregulated in Common Variable Immunodeficiency-Derived B Cells | Q41050545 | ||
| Long-term persistence of the immune response to antipneumococcal vaccines after Allo-SCT: 10-year follow-up of the EBMT-IDWP01 trial | Q41081873 | ||
| Retinoic acid activates interferon regulatory factor-1 gene expression in myeloid cells | Q41189175 | ||
| Normal B cell homeostasis requires B cell activation factor production by radiation-resistant cells | Q42079747 | ||
| Emergent autoimmunity in graft-versus-host disease | Q42194452 | ||
| Common nonmutational NOTCH1 activation in chronic lymphocytic leukemia | Q42291852 | ||
| Synthetic retinoid Am80 ameliorates chronic graft-versus-host disease by down-regulating Th1 and Th17. | Q42723911 | ||
| Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation | Q43682605 | ||
| CD19(+)CD21(low) B cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome. | Q44030095 | ||
| Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. | Q47365613 | ||
| Regulation of bifurcating B cell trajectories by mutual antagonism between transcription factors IRF4 and IRF8. | Q50557277 | ||
| CD24(hi)CD27⁺ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease. | Q50757178 | ||
| Elevated numbers of immature/transitional CD21- B lymphocytes and deficiency of memory CD27+ B cells identify patients with active chronic graft-versus-host disease. | Q51967788 | ||
| Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. | Q51981842 | ||
| B lymphocyte reconstitution after hematopoietic stem cell transplantation: functional immaturity and slow recovery of memory CD27+ B cells. | Q51993431 | ||
| Overexpression of c-fos inhibits down-regulation of a cyclin-dependent kinase-2 inhibitor p27Kip1 in splenic B cells activated by surface Ig cross-linking. | Q52196118 | ||
| Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. | Q53313339 | ||
| IFN regulatory factor 4 and 8 promote Ig light chain kappa locus activation in pre-B cell development. | Q54570916 | ||
| Human marginal zone b cells are not an activated b cell subset: strong expression of cd21 as a putative mediator for rapid b cell activation | Q57892522 | ||
| Functional asplenia after bone marrow transplantation. A late complication related to extensive chronic graft-versus-host disease | Q70210091 | ||
| Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation | Q72046369 | ||
| Etretinate therapy for refractory sclerodermatous chronic graft-versus-host disease | Q77720627 | ||
| A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells | Q78863058 | ||
| Notch activity synergizes with B-cell-receptor and CD40 signaling to enhance B-cell activation | Q79441801 | ||
| Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation | Q80139485 | ||
| A role for c-fos/activator protein 1 in B lymphocyte terminal differentiation | Q81827353 | ||
| Retinoic acid improves defective TLR9/RP105-induced immune responses in common variable immunodeficiency-derived B cells | Q85638420 | ||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2131-2145 | |
| P577 | publication date | 2017-08-29 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD. | |
| P478 | volume | 130 |
| Q50044417 | B-cell targeting in chronic Graft-versus-Host disease |
| Q88573546 | Defining success with cellular therapeutics: the current landscape for clinical end point and toxicity analysis |
| Q90751374 | Developing role of B cells in the pathogenesis and treatment of chronic GVHD |
| Q58782275 | How ibrutinib, a B-cell malignancy drug, became an FDA-approved second-line therapy for steroid-resistant chronic GVHD |
| Q58789958 | NOTCH and Graft-Versus-Host Disease |
| Q57029315 | SYK inhibitor entospletinib prevents ocular and skin GVHD in mice |
| Q92486876 | [Structure and function of B-cell linker and its role in the development of B cell-related diseases] |
Search more.